Related references
Note: Only part of the references are listed.Recovery of cognitive function after relapse in multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses
Sarah A. Morrow et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses
Ralph H. B. Benedict et al.
NEUROLOGY (2021)
Ecological impact of isolated cognitive relapses in MS
Riccardo Meli et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
Lauren Strober et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
Natasa Giedraitiene et al.
SCIENTIFIC REPORTS (2018)
Recommendations for cognitive screening and management in multiple sclerosis care
Rosalind Kalb et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Isolated cognitive relapses in multiple sclerosis
Matteo Pardini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Characterizing cognitive function during relapse in multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Effects of acute relapses on neuropsychological status in multiple sclerosis patients
S. A. Morrow et al.
JOURNAL OF NEUROLOGY (2011)
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline
Sarah A. Morrow et al.
CLINICAL NEUROPSYCHOLOGIST (2010)
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
A. S. Drake et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
S. A. Morrow et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Diagnosis and treatment of multiple sclerosis
TJ Murray
BRITISH MEDICAL JOURNAL (2006)
Reliable screening for neuropsychological impairment in multiple sclerosis
RHB Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Measuring improvement or decline on the WAIS-R in inpatient psychiatry
GL Iverson et al.
PSYCHOLOGICAL REPORTS (2001)